Chandru Subramani
Overview
Explore the profile of Chandru Subramani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma K, Subramani C, Ganesh K, Sharma A, Basu B, Balyan S, et al.
PLoS Pathog
. 2025 Jan;
20(12):e1012816.
PMID: 39775571
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus causing fever, myalgia, and debilitating joint swelling and pain, which in many patients becomes chronic. The frequent epidemics of CHIKV across the world...
2.
Ilinykh P, Huang K, Gunn B, Kuzmina N, Kedarinath K, Jurado-Cobena E, et al.
Commun Biol
. 2024 Jul;
7(1):921.
PMID: 39085489
No abstract available.
3.
Ilinykh P, Huang K, Gunn B, Kuzmina N, Kedarinath K, Jurado-Cobena E, et al.
Commun Biol
. 2024 Jul;
7(1):871.
PMID: 39020082
Antibodies to Ebola virus glycoprotein (EBOV GP) represent an important correlate of the vaccine efficiency and infection survival. Both neutralization and some of the Fc-mediated effects are known to contribute...
4.
Bukreyev A, Meyer M, Gunn B, Pietzsch C, Subramani C, Saphire E, et al.
Res Sq
. 2024 Apr;
PMID: 38585993
The first-ever recent Marburg virus (MARV) outbreak in Ghana, West Africa and Equatorial Guinea has refocused efforts towards the development of therapeutics since no vaccine or treatment has been approved....
5.
Wang S, Guirakhoo F, Periasamy S, Ryan V, Wiggins J, Subramani C, et al.
Vaccines (Basel)
. 2024 Jan;
12(1).
PMID: 38250853
Antibodies provide critical protective immunity against COVID-19, and the Fc-mediated effector functions and mucosal antibodies also contribute to the protection. To expand the characterization of humoral immunity stimulated by subunit...
6.
Subramani C, Sharma G, Chaira T, Barman T
Antiviral Res
. 2023 Nov;
221:105764.
PMID: 38008193
A majority of viral diseases do not have FDA-approved drugs. The recent outbreaks caused by SARS-CoV-2, monkeypox, and Sudan ebolavirus have exposed the critical need for rapid screening and identification...
7.
Kumar A, Subramani C, Raj S, Ranjith-Kumar C, Surjit M
J Virol
. 2023 May;
97(6):e0034723.
PMID: 37199644
Multiple mechanisms exist in a cell to cope with stress. Four independent stress-sensing kinases constitute the integrated stress response machinery of the mammalian cell, and they sense the stress signals...
8.
Chaira T, Subramani C, Barman T
Pharmaceutics
. 2023 Apr;
15(4).
PMID: 37111697
The search for new drugs is an extremely time-consuming and expensive endeavour. Much of that time and money go into generating predictive human pharmacokinetic profiles from preclinical efficacy and safety...
9.
Wang S, Wang C, Kuo H, Peng W, Huang J, Kuo B, et al.
Emerg Microbes Infect
. 2022 Oct;
11(1):2724-2734.
PMID: 36287714
The development of safe and effective vaccines to respond to COVID-19 pandemic/endemic remains a priority. We developed a novel subunit protein-peptide COVID-19 vaccine candidate (UB-612) composed of: (i) receptor binding...
10.
Thiruvengadam R, Awasthi A, Medigeshi G, Bhattacharya S, Mani S, Sivasubbu S, et al.
Lancet Infect Dis
. 2021 Nov;
22(4):473-482.
PMID: 34838183
Background: SARS-CoV-2 variants of concern (VOCs) have threatened COVID-19 vaccine effectiveness. We aimed to assess the effectiveness of the ChAdOx1 nCoV-19 vaccine, predominantly against the delta (B.1.617.2) variant, in addition...